Weaver: Beyond The Numbers

Should Your Bank Consider Banking Cannabis-Related Businesses? with Rachel Mondragon

Informações:

Sinopse

Cannabis-related products and companies squarely live in a world of a perpetual gray area. To help clear up the opaque nature of banking by cannabis-related businesses on this episode of Weaver: Beyond the Numbers, host Shelby Skrhak sits down with Rachel Mondragon, Weaver Senior Manager in Regulatory Compliance specializing in financial institutions, to discuss. The federal Controlled Substances Act makes marijuana a schedule 1 prohibited drug, plant and all, but recent legislation has given states new ability to delineate parts of marijuana, from medicinal CBD all the way to whole decriminalization. The legality of it is gray, so banks, credit card companies, and other financial institutions have kept their distance. "Understandably, you have financial institutions thinking of banking this type of client but they're obviously hesitating," Mondragon said. "Part of that is lack of knowledge and understanding when we make a distinction between marijuana, THC, and CBD." But that's left legitimate CBD businesses